Market Flashes
Bitesize analysis of stocks, indices, commodities, and forex delivered more frequently through the trading day.
-
-
-
Open Orphan leads weighty Wellcome Trust bid to define human challenge drug standards
-
Excitement Builds as Cyon Exploration Identifies Promising Drilling Locations
-
Open Orphan lands another £2.5m flu challenge study contract
-
Touchstone Exploration raises $30m to capitalise on incredible Ortoire opportunity
-
Open Orphan extends pharmacometrics relationship with tier 1 German pharma company
-
Touchstone Exploration upbeat as Cascadura Deep spuds ahead of schedule
-
AUX Resources completes 3,600 metres of drilling within the Golden Triangle
-
Massive sulphides and MASSIVE potential in the Kalahari Suture Zone for Kavango Resources
-
Ariana Resources Releases Mineral Resource Estimate for Cyprus Magellan Project
-
Open Orphan reveals transformational Covid-19 vaccine contract with UK government
-
-
-
Open Orphan hits record highs after winning £4.3m vaccine contract
-
Numinus commences Psilocybe Mushroom cultivation at its Health Canada Licensed Laboratory
-
Starr Peak Neighbour Reports Exciting Surface Gold Bearing System.
-
BREAKING NEWS: Numinus Announces Closing of Oversubscribed $4.6 Million Offering
-
AUX Resources completes acquisition of two highly prospective properties within the Golden Triangle
-
-
EarthRenew announces preliminary results from feasibility study with a potential partner
-
-
-
Conroy Gold makes Irish gold breakthrough with €4m Anglo Asian JV (CGNR)
-
All eyes on Q2 2020 US earnings season as stock markets hang in the balance
-
Key human challenge expert Adrian Wildfire rejoins hVIVO for Open Orphan boost (ORPH)
-
Fiore Gold (TSX-V:F│OTCQB:FIOGF│FSE:2FO)– An intermediate gold producer in the making
-
Bahamas Petroleum wins 30-year Argentina offshore licence (BPC)
-
-
-
-
Dart Group is flying as UK-Euro travel opens up, looks a solid trade (DTG)
-
-
-
Open Orphan share price spikes as Covid-19 home testing stocks rocket (ORPH)
-
-
-
Omega Diagnostics ramps up Covid-19 antibody tests to 1 million a month, could fly higher (ODX)
-
Investors expect Netflix to get big lockdown boost in Q1 (NFLX)
-
Going long on insolvency as crippled UK businesses face dark days (MANO, BEG)
-
What Q1 bank earnings season tells us about the US economy (C, GS, JPM, BAC)
-
Uranium rockets as supply is whacked by Covid-19 (CCJ, YCA, GCL)
-
New contracts mean it is time to give TP Group its due (TPG)
-
Cineworld spikes on dividend cut, but serious concerns remain (CINE)
-
Beware the sucker rally: 2020 is still going to be a horrorshow for equities
-
Down but far from out – Covid-19’s long-term impact on battery metal markets
-
Why William Hill’s recovery is primed to continue in UK lockdown (WMH)
-
-
No bottom in sight for UK stock markets: When should investors buy?
-
-
Airbnb IPO could be the biggest casualty of the 2020 stock market collapse
-
AIM’s existential crisis – Will more firms fail as funding evaporates?
-
Why I’m backing high-yield FTSE 100 insurance stocks to beat the market crash (LGEN, AV)
-
Open Orphan’s Cathal Friel on firm’s “milestone” human coronavirus challenge study (ORPH)
-
-
Touchstone Exploration reveals strong progress in 2019 reserves report (TXP)
-
Open Orphan signs £3.2m challenge study deal with upside potential (ORPH)
-
The Shifting Shares View: Is InnovaDerma a buy following half year results? (IDP)
-
-
First profits and underlying business growth make YourGene a buy (YGEN)
